rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Concentra Group Holdings Parent, Inc.

CON · NYSE

Health CareProviders & FacilitiesLeading

CON stood above a rising 150-day average in 32 of the last 52 weekly readings, including each of the last 25 weeks. It is 31.8% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
25 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$29.2M
Officials’ trades on record
2
Institutions holding
266 (+13)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 32 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$8.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k25 Sep 2025filed 22 Oct 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k11 Sep 2025filed 22 Oct 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 1
WhoDidSharesTraded
Robert A. OrtenzioDirectorsold130,000at $31.843 Aug 2026filed 5 Aug 2026
Robert A. OrtenzioDirectorsold130,000at $30.501 Jul 2026filed 6 Jul 2026
Robert A. OrtenzioDirectorsold130,000at $25.001 Jun 2026filed 2 Jun 2026
Robert A. OrtenzioDirectorsold130,000at $25.008 May 2026filed 11 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders266+13 on the quarter
New · exited54 · 41
Reported value$2.7B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202617,753,714$528.2M+686,364+4.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20266,817,456$202.8M+78,531+1.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20265,129,815$152.6M+34,299+0.7%
STATE STREET CORPadded · filed 7 Aug 20264,840,099$144.0M+237,274+5.2%
JENNISON ASSOCIATES LLCadded · filed 3 Aug 20263,256,435$96.9M+1,084,144+49.9%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20263,225,694$96.0M+118,440+3.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20263,099,790$92.2M+166,616+5.7%
Invesco Ltd.added · filed 14 Aug 20262,922,867$87.0M+255,673+9.6%
JPMORGAN CHASE & COnew · filed 12 Aug 20262,780,432$82.9M+2,780,432
BARROW HANLEY MEWHINNEY & STRAUSS LLCreduced · filed 12 Aug 20262,702,531$80.4M-504,773−15.7%
30 Sep 2024 – 30 Jun 2026
74167259Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Robert A. Ortenzio Company insiderDirector · last 21 Aug 20260 · 4
William Keith Newton Company insiderChief Executive Officer · last 17 Dec 20250 · 0
Danielle Kendall Company insiderOfficer · last 26 Nov 20250 · 0
Douglas R. McAndrew Company insiderOfficer · last 26 Nov 20250 · 0
Giovanni Gallara Company insiderOfficer · last 26 Nov 20250 · 0
Greg M. Gilbert Company insiderOfficer · last 26 Nov 20250 · 0
John A. Delorimier Company insiderOfficer · last 26 Nov 20250 · 0
John Robert Anderson, Jr. Company insiderOfficer · last 26 Nov 20250 · 0
Jonathan P. Conser Company insiderOfficer · last 26 Nov 20250 · 0
Matthew T. Dicanio Company insiderOfficer · last 26 Nov 20250 · 0
Michael A. Kosuth Company insiderOfficer · last 26 Nov 20250 · 0
Michael D. Rhine Company insiderOfficer · last 26 Nov 20250 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202515.4%
Free cash flow marginFY 2025 · to 31 Dec 20259.1%
Return on capital employedFY 2025 · to 31 Dec 202513.2%
Cash conversionFY 2025 · to 31 Dec 2025168%
Dividend growthFY 2025 · to 31 Dec 2025300%
Share count trendFY 2025 · to 31 Jan 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$79.9M
Free cash flowFY 2025 · to 31 Dec 2025$197.1M

Analyst forecasts

No analyst forecasts yet.